| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2011 | CN102131801A 1, 2 disubstituted heterocyclic compounds |
| 07/20/2011 | CN102131800A 5- and 6-membered heterocyclic compounds |
| 07/20/2011 | CN102131799A Method for splitting omeprazole salts |
| 07/20/2011 | CN102131798A Di-substituted phenyl compounds used as inhibitors of phosphodiesterase 10 |
| 07/20/2011 | CN102131797A Triazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 07/20/2011 | CN102131794A 6-substituted phenoxychroman carboxylic acid derivatives |
| 07/20/2011 | CN102131791A Dibenzothiazepine derivatives and use thereof |
| 07/20/2011 | CN102131790A Novel phenolic and catecholic amines and prodrugs thereof |
| 07/20/2011 | CN102131788A Compounds and compositions as protein kinase inhibitors |
| 07/20/2011 | CN102131785A 6-substituted isoquinolines and isoquinolinones |
| 07/20/2011 | CN102131784A Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 07/20/2011 | CN102131783A Quinoline derivatives as axl kinase inhibitors |
| 07/20/2011 | CN102131782A Pyridine derivatives as VEGF-2 receptor and protein tyrosine kinase inhibitors |
| 07/20/2011 | CN102131781A 1-(4-ureidobenzoyl)piperazine derivatives |
| 07/20/2011 | CN102131780A Novel piperidine-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/20/2011 | CN102131779A Novel piperidine-4-acetamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/20/2011 | CN102131778A Heterocyclic gpcr agonists |
| 07/20/2011 | CN102131777A Piperidyl acrylamide antogonists of CCR2 |
| 07/20/2011 | CN102131776A Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof |
| 07/20/2011 | CN102131775A Small molecule inhibitors of N-terminus activation of the androgen receptor |
| 07/20/2011 | CN102131774A Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 07/20/2011 | CN102131771A Compositions and methods for preparing and using same |
| 07/20/2011 | CN102131765A Orally active curcuminoid compounds |
| 07/20/2011 | CN102131525A Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 07/20/2011 | CN102131514A Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| 07/20/2011 | CN102131510A Cardioplegic preparation |
| 07/20/2011 | CN102131509A Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases |
| 07/20/2011 | CN102131508A Treatment of anxiety disorders |
| 07/20/2011 | CN102131507A Film preparation containing loperamide hydrochloride |
| 07/20/2011 | CN102131506A Polymorphic form of granisetron hydrochloride and methods of making the same |
| 07/20/2011 | CN102131505A Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity |
| 07/20/2011 | CN102131504A Combinations comprising bicyclic S1P lyase inhibitors |
| 07/20/2011 | CN102131503A Combination products comprising mGluR modulator for treating parkinson's disease |
| 07/20/2011 | CN102131502A Nutritional composition for improving mammalian immune system |
| 07/20/2011 | CN102131501A Antitumor properties of no modified protease inhibitors |
| 07/20/2011 | CN102131399A Nutritional composition for infants delivered via caesarean section |
| 07/20/2011 | CN102131390A Triazolopyridine jak inhibitor compounds and methods |
| 07/20/2011 | CN102131389A Triazolopyridine JAK inhibitor compounds and methods |
| 07/20/2011 | CN102127231A Glucan/polycaprolactone amphiphilic block polymer and preparation method and application thereof |
| 07/20/2011 | CN102127172A Water-soluble coenzyme Q 10 compound and preparation method thereof |
| 07/20/2011 | CN102127142A Ilicis routundae cortex derivants and application thereof in preparing medicament capable of resisting tumors |
| 07/20/2011 | CN102127141A Esculentoside A, EsA as well as preparation method and application thereof |
| 07/20/2011 | CN102127133A 6-11 bicyclic ketolide derivatives |
| 07/20/2011 | CN102127120A Antitumor platinum(II) complex and use thereof in preparation of antitumor medicine |
| 07/20/2011 | CN102127114A Non-natural chiral amino acid derivative with di-organic phosphate group and synthesis method thereof |
| 07/20/2011 | CN102127097A N-(3S-1, 2, 3, 4- tetrahydroisoquinoline-3-formoxyl) cupric amino-acid complex, preparation method and application of complex |
| 07/20/2011 | CN102127096A Triazole pyridine and triazole pyrazine compound and composition and application thereof |
| 07/20/2011 | CN102127091A Heterocyclic ring-containing schiff base compound |
| 07/20/2011 | CN102127087A 喹唑啉衍生物 Quinazoline derivatives |
| 07/20/2011 | CN102127086A Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
| 07/20/2011 | CN102127080A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 07/20/2011 | CN102127079A Pyrrolo-pyrazin-carboline diketone compounds and preparation method and applications thereof |
| 07/20/2011 | CN102127078A Heterocyclic janus kinase 3 inhibitors |
| 07/20/2011 | CN102127074A 6-sulfamyl substituted-beta-carboline-1-ketone cell cycle protein dependent kinase 2 inhibitor and application thereof |
| 07/20/2011 | CN102127072A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127071A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127070A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127069A Tiotropium bromide crystal |
| 07/20/2011 | CN102127067A 2-(6-aminobenzothiazole-2-mercapto)-acetamide derivatives and preparation method and applications thereof |
| 07/20/2011 | CN102127062A Substituted isoandrographolide derivative, preparation method and medical application thereof |
| 07/20/2011 | CN102127058A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 07/20/2011 | CN102127057A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127056A Tubulin inhibitors |
| 07/20/2011 | CN102127054A 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite |
| 07/20/2011 | CN102127053A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127050A Bisbibenzyl Mannich base derivative, preparation method and application thereof |
| 07/20/2011 | CN102127046A 4', 5-dyhydroxyl-7-(4-(N, N-diethylamino group) butoxy) isoflavone, preparation method and application of 4', 5-dyhydroxyl-7-(4-(N, N-diethylamino group) butoxy) isoflavone |
| 07/20/2011 | CN102127042A Homoisoflavonoid compounds and preparation method and use thereof |
| 07/20/2011 | CN102127041A Sialic acid analog and application thereof to preparation of anti-influenza-virus medicaments |
| 07/20/2011 | CN102127037A Tanshinone compounds and applications thereof |
| 07/20/2011 | CN102127033A Febuxostat crystal form and industrial preparation method thereof |
| 07/20/2011 | CN102127030A 4-(substituted-1,3-dialkynyl)-4-(trifluoromethyl)benzo-1,4-dihydroxazole-2-one compounds and preparation method and applications thereof |
| 07/20/2011 | CN102127019A Geldanamycin derivative, preparation thereof and medicament application thereof |
| 07/20/2011 | CN102127016A Hetisin type diterpenoid alkaloid and preparation method and application thereof |
| 07/20/2011 | CN102127004A New derivatives of azabicyclo[3.2.0]hept-3-yl, method for preparing same and pharmaceutical compositions containing them |
| 07/20/2011 | CN102126999A Catalytic synthesis method of chiral azetidin-2-one-4-amide and carboxylic acid compounds in microorganism system |
| 07/20/2011 | CN102126998A Endothelin antagonist |
| 07/20/2011 | CN102126993A Resveratrol derivative and application thereof to preparation of antitumor medicaments |
| 07/20/2011 | CN102126983A Colchicin derivative, preparation method and application thereof |
| 07/20/2011 | CN102126973A Meglumine compound of dibasic ester acid and preparation method and medicinal application thereof |
| 07/20/2011 | CN102126938A Curcumin analog and preparation method and application thereof |
| 07/20/2011 | CN102126934A Paraterphenyl derivative and application thereof to preparation of antitumor medicaments |
| 07/20/2011 | CN102126933A Diphenyl propane lignan compound and preparation method thereof |
| 07/20/2011 | CN102125697A Chlorambucil/layered double hydroxides nano-hybrid and preparation method thereof |
| 07/20/2011 | CN102125696A Oligomeric ribonucleic acid composite for inhibiting tumor growth and angiogenesis and application thereof |
| 07/20/2011 | CN102125694A Conjugate of liver cancer specifically targeted peptide A54 and amycin and coupling method and application thereof |
| 07/20/2011 | CN102125693A Tiagabine hydrochloride pharmaceutical composition and preparation method thereof |
| 07/20/2011 | CN102125692A Wrapping agent in levo-carnitine wrapping technology and composition of ten series products and preparation method |
| 07/20/2011 | CN102125691A Nano-medicament carrying system of acetylcholine medicament |
| 07/20/2011 | CN102125689A Compound preparation of proton pump inhibitor and domperidone |
| 07/20/2011 | CN102125688A Medicinal composition for treating gastric ulcer |
| 07/20/2011 | CN102125680A Anticancer traditional Chinese medicinal composition and use thereof |
| 07/20/2011 | CN102125672A Traditional Chinese medicine for treating cervical and lumbar spinal diseases and preparation method thereof |
| 07/20/2011 | CN102125666A Traditional Chinese medicinal preparation for treating burn |
| 07/20/2011 | CN102125665A Active plaster for treating blood stasis of human bodies |
| 07/20/2011 | CN102125659A Enema for treating prostatic diseases |
| 07/20/2011 | CN102125657A Spray formulation for treating beriberi |
| 07/20/2011 | CN102125637A Externally applied Chinese medicine bag |
| 07/20/2011 | CN102125628A Formula of externally applied medicine for quickly expelling wind and clearing away cold and freeing network vessels and removing obstruction in channels |
| 07/20/2011 | CN102125616A New five-kernel pill and new five-kernel paste and preparation methods thereof |